The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative Tool: The Vitiligo Area Scoring Index
Abstract
BACKGROUND: There is currently no quantitative tool for evaluating vitiligo treatment response using parametric methods. OBJECTIVE: To develop and apply a simple clinical tool, the Vitiligo Area Scoring Index (VASI), to model the response of vitiligo to narrowband UV-B (NB-UV-B) phototherapy using parametric tests. DESIGN: Prospective, randomized, controlled, bilateral left-right comparison trial. SETTING: North American tertiary care, university-affiliated phototherapy center. PATIENTS: Patients older than 18 years with stable vitiligo involving at least 5% of their total body surface in a symmetric distribution. INTERVENTION: Treatment with NB-UV-B was given 3 times a week to half of the body on all patients for either 60 treatments or 6 months. The contralateral side served as a no-treatment control. MAIN OUTCOME MEASURE: Repigmentation was assessed using the VASI, which was based on a composite estimate of the overall area of vitiligo patches at baseline and the degree of macular repigmentation within these patches over time. The VASI was validated separately against physician and patient global assessments. The overall reductions in VASI for NB-UV-B and control groups were modeled by multilevel regression with random effects and compared parametrically. RESULTS: The VASI scoring correlated well with both patient and physician global assessments (P =.05 and P<.001, respectively, using ordinal logistic regression). The extent of repigmentation after 6 months on the treated side was 42.9% (95% confidence interval, 26.7%-59.0%) vs 3.3% (95% confidence interval -19.3% to 30.0%) on the untreated side (P<.001). A significant difference between control and NB-UV-B groups was apparent within the first 2 months of therapy. The legs, trunk, and arms were much more likely to repigment than the feet and hands. CONCLUSIONS: The VASI is a quantitative clinical tool that can be used to evaluate vitiligo parametrically. Patients treated with NB-UV-B can be expected to achieve approximately 42.9% repigmentation of their vitiligo after 6 months of treatment, with the greatest response being achieved over the trunk and nonacral portions of the extremities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Treatment of Vitiligo With UV-B Radiation vs Topical Psoralen Plus UV-A
Westerhof, W. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.12.1525 · Cited by 370
Role of Hair Follicles in the Repigmentation of Vitiligo
Cui, J., Shen, L.-Y., & Wang, G.-C. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12480997 · Cited by 341
Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo
Scherschun, L., Kim, J. J., & Lim, H. W. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114752 · Cited by 302
Multilevel time series models with applications to repeated measures data
Goldstein, H., Healy, M. J. R., & Rasbash, J. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131605 · Cited by 285
Nonsurgical Repigmentation Therapies in Vitiligo: Meta-analysis of the Literature
Njoo, M. D., Spuls, P. I., Bos, J. D., Westerhof, W., & Bossuyt, P. M. M. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.12.1532 · Cited by 258
Outcome Measures of Disease Severity in Atopic Eczema
Charman, C., & Williams, H. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.6.763 · Cited by 203
Quantification of the Extent and the Severity of Atopic Dermatitis: The ADASI Score
Bahmer, F. A. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680070141025 · Cited by 53
Cited by
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00997.x · Cited by 702
Self-citationThe definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force
Taïeb, A., Picardo, M., & members, O. B. O. T. O. V. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00355.x · Cited by 517
Taïeb, A., & Picardo, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0804388 · Cited by 352
Guideline for the diagnosis and management of vitiligo
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08881.x · Cited by 332
Whitton, M. E., Pinart, M., Batchelor, J., Leonardi-Bee, J., González, U., Jiyad, Z., Eleftheriadou, V., & Ezzedine, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003263.pub5 · Cited by 304
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Rosmarin, D., Pandya, A. G., Lebwohl, M., Grimes, P., Hamzavi, I., Gottlieb, A. B., Butler, K., Kuo, F., Sun, K., Ji, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30609-7 · Cited by 271
Self-citationBritish Association of Dermatologists guidelines for the management of people with vitiligo 2021
Eleftheriadou, V., Atkar, R., Batchelor, J., McDonald, B., Novakovic, L., Patel, J. V., Ravenscroft, J., Rush, E., Shah, D., Shah, R., et al. (2022) · British Journal of Dermatology · doi:10.1111/bjd.20596 · Cited by 122
Guo, L., Yang, Y., Ding, H., Zheng, H., Yang, H., Xie, J., Li, Y., Lin, T., & Ge, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1738 · Cited by 62
“This metric was more objective than VASI assessment, and it was calculated directly on clinical images, thus making it easier to conduct than other equipment-based colorimetric analysis.”
InfluentialEvaluation of Facial Vitiligo Severity with a Mixed Clinical and Artificial Intelligence Approach
Hillmer, D., Merhi, R., Boniface, K., Taieb, A., Barnetche, T., Seneschal, J., & Hagedorn, M. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.07.014 · Cited by 37
Metadata
- Authors
- Hamzavi, I., Jain, H., McLean, D., Shapiro, J., Zeng, H., & Lui, H.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-06-01
- Volume
- 140
- Issue
- 6
- Pages
- 677-83
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2072712987
- Cited by
- 452
- References
- 8
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.